Information  X 
Enter a valid email address

Company Name matching 'RECORDATI'

Date
Time Source
Company
Announcement
26 Mar 2020 1:15 pm GNW   RECORDATI RECORDATI SUBMITS NEW DRUG APPLICATION FOR ISTURISA® IN JAPAN
18 Mar 2020 1:42 pm GNW   RECORDATI RECORDATI CONTRIBUTES TO SUPPORT HOSPITALS AND PATIENTS IN THE FACE OF THE EPIDEMIOLOGIC EMERGENCY DUE TO COVID-19
  1:22 pm GNW   RECORDATI BOARD APPROVES THE 2019 ACCOUNTS. SALES € 1,481.8 MILLION (+9.6%), EBITDA € 544.0 MILLION (+9.0%). 2019 DIVIDEND € 1.00 (+8.7%)
14 Feb 2020 1:11 pm GNW   RECORDATI RECORDATI: PRELIMINARY 2019 RESULTS CONFIRM CONTINUED GROWTH OF SALES AND PROFITS. SALES +9.6%. EBITDA +9.0%
15 Jan 2020 11:13 am GNW   RECORDATI RECORDATI: ISTURISA® (OSILODROSTAT) APPROVED
15 Nov 2019 4:34 pm GNW   RECORDATI RECORDATI: CHMP ADOPTS POSITIVE OPINION FOR ISTURISA® (OSILODROSTAT)
31 Oct 2019 12:01 pm GNW   RECORDATI RECORDATI ANNOUNCES GROWTH IN THE FIRST NINE MONTHS 2019. REVENUES +8.6%, EBITDA +7.8%, OPERATING INCOME +4.9%, NET INCOME +6.6%. INTERIM DIVIDEND € 0.48 (+6.7%).
23 Oct 2019 11:06 am GNW   RECORDATI RECORDATI: ACQUISITION OF WORLDWIDE RIGHTS TO SIGNIFOR® AND OSILODROSTAT (LCI699) COMPLETED
30 Jul 2019 12:21 pm GNW   RECORDATI RECORDATI ANNOUNCES GROWTH IN THE FIRST HALF 2019. REVENUES +6.8%, EBITDA(1) +7.4%, NET INCOME +6.1%
12 Jul 2019 7:30 pm GNW   RECORDATI RECORDATI TO ACQUIRE WORLDWIDE RIGHTS TO SIGNIFOR® AND OSILODROSTAT (LCI699)
24 Jun 2019 7:35 am GNW   RECORDATI RECORDATI RARE DISEASES, A WORLDWIDE LEADER IN RARE DISEASES AND ORPHAN DRUGS
08 May 2019 11:27 am GNW   RECORDATI RECORDATI ANNOUNCES GROWTH IN THE FIRST QUARTER 2019. NEW THREE YEAR BUSINESS PLAN APPROVED
15 Apr 2019 8:10 am GNW   RECORDATI RECORDATI TO MEET WITH THE FINANCIAL COMMUNITY
11 Apr 2019 1:41 pm GNW   RECORDATI RECORDATI SHAREHOLDERS APPROVE THE 2018 ACCOUNTS. DIVIDEND € 0.92 PER SHARE (+8.2% vs 2017)
28 Feb 2019 2:12 pm GNW   RECORDATI RECORDATI: BOARD APPROVES THE 2018 ACCOUNTS. SALES € 1,352.2 MILLION (+5.0%), EBITDA € 499.1 MILLION (+9.8%), OPERATING INCOME € 442.2 MILLION (+8.8%) AND NET INCOME € 312.4 MILLION (+8.2%). 2018 DIVIDEND € 0.92 (+8.2%)
11 Feb 2019 11:57 am GNW   RECORDATI RECORDATI: PRELIMINARY 2018 RESULTS CONFIRM CONTINUED GROWTH OF SALES AND PROFITABILITY. SALES +5.0%, EBITDA +9.8%, OPERATING INCOME +8.8%, NET INCOME +8.2%
06 Feb 2019 7:30 am GNW   RECORDATI RECORDATI OBTAINS EXCLUSIVE LICENSE FOR JUXTAPID® IN JAPAN
21 Dec 2018 1:04 pm GNW   RECORDATI RECORDATI ACQUIRES TONIPHARM S.A.S. IN FRANCE
20 Dec 2018 7:32 am GNW   RECORDATI RECORDATI AND HELSINN AGREEMENT FOR THE EXCLUSIVE COMMERCIALIZATION RIGHTS TO LEDAGA®
05 Dec 2018 1:16 pm GNW   RECORDATI RECORDATI RECEIVES ORPHAN DRUG DESIGNATION FOR ITS INVESTIGATIONAL TREATMENT FOR NEUROTROPHIC KERATITIS
05 Nov 2018 2:17 pm GNW   RECORDATI RECORDATI RECEIVES ORPHAN DRUG DESIGNATION FOR ITS INVESTIGATIONAL TREATMENT FOR MSUD
30 Oct 2018 12:24 pm GNW   RECORDATI RECORDATI ANNOUNCES SALES AND MARGIN GROWTH IN THE FIRST NINE MONTHS 2018. REVENUES +5.1%, EBITDA +11.1%, OPERATING INCOME +9.6%, NET INCOME +8.2%. INTERIM DIVIDEND € 0.45 (+7.1%)
12 Sep 2018 4:47 pm GNW   RECORDATI THE NINTH EDITION OF THE INTERNATIONAL PRIZE FOR SCIENTIFIC RESEARCH ARRIGO RECORDATI HAS ANNOUNCED THE CALL FOR NOMINATIONS
26 Jul 2018 11:30 am GNW   RECORDATI RECORDATI ANNOUNCES SALES AND MARGIN GROWTH IN THE FIRST HALF 2018. REVENUES +6.9%, OPERATING INCOME +14.1%, NET INCOME +11.7%
11 Jun 2018 2:01 pm GNW   RECORDATI RECORDATI ACQUIRES NATURAL POINT S.R.L. IN ITALY
08 May 2018 10:27 am GNW   RECORDATI RECORDATI ANNOUNCES SALES AND MARGIN GROWTH IN THE FIRST QUARTER 2018. REVENUES +7.2%, OPERATING INCOME +12.4%, NET INCOME +10.3%
09 Apr 2018 7:31 am GNW   RECORDATI RECORDATI ACQUIRES INTERNATIONAL RIGHTS TO CYSTAGON® FROM MYLAN
15 Mar 2018 11:17 am GNW   RECORDATI RECORDATI: BOARD APPROVES THE 2017 ACCOUNTS. SALES € 1,288.1 MILLION (+11.6%), OPERATING INCOME € 406.5 MILLION (+24.1%) AND NET INCOME € 288.8 MILLION (+21.6%). 2017 DIVIDEND € 0.85 (+21.4%)
08 Feb 2018 11:25 am GNW   RECORDATI RECORDATI: PRELIMINARY 2017 RESULTS CONFIRM CONTINUED GROWTH OF SALES AND PROFITABILITY. SALES +11.6%, OPERATING INCOME +24.1%, NET INCOME +21.6%
18 Dec 2017 7:31 am GNW   RECORDATI RECORDATI: ACQUIRES TRANSIPEG®, TRANSIPEGLIB® AND COLOPEG® FOR THE FRENCH MARKET
26 Oct 2017 11:01 am GNW   RECORDATI RECORDATI: VERY GOOD RESULTS IN THE FIRST NINE MONTHS 2017. CONTINUED GROWTH IN SALES +11.8%, OPERATING INCOME +21.8%, NET INCOME +20.6%. INTERIM DIVIDEND € 0.42 (+20%)
27 Jul 2017 10:24 am GNW   RECORDATI RECORDATI: VERY GOOD RESULTS IN THE FIRST HALF 2017. CONTINUED GROWTH IN SALES +10.7%, OPERATING INCOME +19.4%, NET INCOME +19.8%
19 Jul 2017 8:08 am GNW   RECORDATI RECORDATI: THE EUROPEAN COMMISSION APPROVES REAGILA® (CARIPRAZINE) FOR THE TREATMENT OF SCHIZOPHRENIA
09 Oct 2014 1:32 pm GNW   RECORDATI RECORDATI : initiates a share buy-back program
16 Sep 2014 8:18 am GNW   RECORDATI RECORDATI : OBTAINS LICENSE TO NEW TREATMENT FO...
29 Jul 2014 12:05 pm GNW   RECORDATI RECORDATI REPORTS EXCELLENT RESULTS IN THE FIRS...
03 Jul 2014 11:53 am GNW   RECORDATI RECORDATI : CARBAGLU® RECEIVES ORPHAN DRUG...
26 May 2014 2:23 pm GNW   RECORDATI RECORDATI FINALIZES THE SECOND TRANCHE OF ITS A...
17 Apr 2014 1:15 pm GNW   RECORDATI RECORDATI : SHAREHOLDERS APPROVE THE 2013 ACCOU...
06 Mar 2014 12:04 pm GNW   RECORDATI RECORDATI: BOARD APPROVES THE 2013 ACCOUNTS.
26 Feb 2014 11:00 am GNW   RECORDATI The European Organisation for Rare Diseases awa...
11 Feb 2014 11:14 am GNW   RECORDATI RECORDATI : PRELIMINARY 2013 RESULTS SHOW SIGNI...
10 Feb 2014 12:02 pm GNW   RECORDATI RECORDATI : OBTAINS VITAROS® LICENSE FROM ...
16 Jan 2014 2:45 pm GNW   RECORDATI RECORDATI BOARD OF DIRECTORS APPROVES 2014 OBJ...
31 Oct 2013 1:51 pm GNW   RECORDATI RECORDATI : FINALIZES THE FIRST TRANCHE OF ITS ...
30 Oct 2013 12:13 pm GNW   RECORDATI RECORDATI REPORTS SIGNIFICANT GROWTH IN THE FI...
21 Oct 2013 8:38 am GNW   RECORDATI RECORDATI FINALIZES ITS ACQUISITION OF LABORAT...
23 Sep 2013 8:51 am GNW   RECORDATI RECORDATI : ANDREA RECORDATI APPOINTED CHIEF OP...
09 Sep 2013 8:38 am GNW   RECORDATI RECORDATI :ACQUIRES THE SPANISH PHARMACEUTICAL ...
25 Jul 2013 10:56 am GNW   RECORDATI RECORDATI REPORTS EXCELLENT RESULTS IN THE FIRS...
24 Jul 2013 3:06 pm GNW   RECORDATI RECORDATI ACQUIRES THE TUNISIAN PHARMACEUTICAL ...
09 May 2013 11:58 am GNW   RECORDATI RECORDATI : SIGNIFICANT SALES AND EARNINGS GROW...
17 Apr 2013 2:00 pm GNW   RECORDATI RECORDATI : SHAREHOLDERS APPROVE THE 2012 ACCOU...
07 Mar 2013 3:07 pm GNW   RECORDATI DISREGARD PREVIOUS RELEASE - RECORDATI : Board...
  12:00 pm GNW   RECORDATI RECORDATI : Board approves the 2012 accounts.
13 Feb 2013 7:58 am GNW   RECORDATI RECORDATI : POSITIVE PRELIMINARY 2012 RESULTS. ...
21 Jan 2013 8:19 am GNW   RECORDATI RECORDATI : FINALIZES ITS ACQUISITION OF A PORT...
23 Nov 2012 7:39 am GNW   RECORDATI RECORDATI LICENSES GRASPA® FROM ERYTECH IN...
25 Oct 2012 12:14 pm GNW   RECORDATI RECORDATI : POSITIVE FIRST NINE MONTHS 2012 RES...
16 Oct 2012 8:13 am GNW   RECORDATI RECORDATI : ACQUIRES A PORTFOLIO OF PRODUCTS IN...


Company Announcements Archive »

 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t